Pleoma

Altheus Therapeutics

Altheus Therapeutics was established to develop novel therapies for Inflammatory Bowel Disease (IBD). Our technologies, developed at the University of Oklahoma, are the result of 30 years of research and insight into the disease. Our product candidates show drastic increase in efficacy versus the current frontline treatment, meaning the potential for less suffering and more active lives for those with the disease.

AA Zentivus

AA Zentivus the global pharma industry's innovative and reliable procurement partner. AA Zentivus' attention to service and detail has made us an industry leader. Our core sectors are sourcing and supplying active pharmaceutical ingredients, intermediates and speciality chemicals to pharmaceutical markets globally. We have the strength and extensive supplier base to enable exacting quantities and the highest quality grade products to serve our client base.

Allodynic Therapeutics, LLC

Allodynic Therapeutics is a clinical-stage biopharma company engaged in developing naltrexone-acetaminophen (ALLOD-2) as an oral investigational product for the acute treatment of migraine. Both naltrexone and acetaminophen individually can simultaneously reduce physical and emotional pain, potentially enhancing treatment outcomes. Naltrexone-acetaminophen U.S. patents extend to 2037.

UnderJungle

Hemp and Cannabis Community